Recall
FDAHealthNovember 26, 2025

SOMERSET THERAPEUTICS LLC — Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, F

⚠️ Subpotent product:out of specification assay results observed during long term stability testing.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
November 26, 2025

Nationwide in the USA

What's affected?

Product
Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.
UPC
0370069161012
Lot code
A250043

Additional details

Lot#: A250043, EXP Date 06/30/2026

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 71,310 10mL vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.